Tardío Juan C, Granados Rosario
Hospital Universitario de Fuenlabrada, Madrid, Spain
Hospital Universitario de Getafe, Madrid, Spain.
Int J Surg Pathol. 2015 Aug;23(5):424-8. doi: 10.1177/1066896915579103. Epub 2015 Mar 31.
Till date, there is only one reported case of breast implant-associated ALK-negative anaplastic large cell lymphoma (ALCL) with an axillary presentation that followed an aggressive behavior. We report the case of a 50-year-old female presenting with an axillary lymphadenopathy 8 years after breast prostheses implantation. Clinical examination, ultrasound, and magnetic resonance imaging detected no mammary lesions. The lymph node showed intrasinusoidal infiltration by large pleomorphic cells expressing CD30 and lacking ALK-immunoreactivity. Tumor staging was negative. Cells with identical features were found in the ipsilateral periprosthetic capsule. The patient was treated with CHOP and radiotherapy, and she is alive without evidence of disease after a 30-month follow-up. The diagnosis of an ALK-negative ALCL in an axillary lymph node of a patient with ipsilateral breast prosthesis and negative staging should prompt removal of the implant with capsulectomy, since the pathological study of this specimen allows the correct diagnosis with important prognostic implications.
迄今为止,仅有一例报告的乳房植入物相关的ALK阴性间变性大细胞淋巴瘤(ALCL),表现为腋窝肿物且具有侵袭性行为。我们报告一例50岁女性,在乳房假体植入8年后出现腋窝淋巴结病。临床检查、超声及磁共振成像均未发现乳腺病变。淋巴结显示大量表达CD30且缺乏ALK免疫反应性的多形性细胞呈窦内浸润。肿瘤分期为阴性。在同侧假体周围包膜中发现了具有相同特征的细胞。患者接受了CHOP方案化疗及放疗,30个月随访后仍存活且无疾病证据。对于同侧乳房假体且分期为阴性的患者,腋窝淋巴结诊断为ALK阴性ALCL时,应行假体及包膜切除术,因为对该标本进行病理研究有助于做出正确诊断并具有重要的预后意义。